Product Recalls: June 15, 2022 – July 20, 2022
Health Letter, August 2022
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS I
CLASS II
Clonazepam orally disintegrating tablets, 0.125mg, 60 tablets. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: MHC1430A, exp. date: 09/2023.
Desmopressin acetate tablets, 0.2 mg, 100-count bottles. Manufactured for: Northstar Rx LLC. Manufactured by: Glenmark Pharmaceuticals Ltd. Lot #: 20020121, exp. date: 01/2024.
Enalapril maleate tablets; 2.5, 5, 10 or 20 mg; 90 tablets. Manufactured by: Taro Pharmaceutical Industries, Ltd. Lot #: GS028301, exp. date: 06/2022; Lot #: GS029973, GS029974, GS031436, GS031715, GS033191 or GS033940, exp. date: 10/2022; Lot #: GS034212, exp. date: 12/2022; Lot #: GS035315, GS035945, GS036905, GS038038 or GS039199, exp. date: 04/2023; Lot #: GS039200 or GS040149, exp. date: 11/2023; Lot #: GS029041, GS029353 or GS02986, exp. date: 09/2022; Lot #: GS030056, GS030869 or GS033943, exp. date: 10/2022; Lot #: GS034490 or GS035197, exp. date: 02/2023; Lot #: GS035198, exp. date: 03/2023; Lot #: GS035596, GS035947, GS036759 or GS037400, exp. date: 06/2023; Lot #: GS038089, GS038763, GS039559 or GS040150, exp. date: 10/2023; Lot #: GS040151, GS040708 or GS041107, exp. date: 12/2023; Lot #: GS041654, exp. date: 03/2024; Lot #: GS027890, GS028177 or GS028488, exp. date: 04/2022; Lot #: GS028847 or GS028848, exp. date: 09/2022; Lot #: GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527 or GS034231, exp. date: 10/2022; Lot #: GS034810, exp. date: 01/2023; Lot #: GS035240 or GS035598, exp. date: 05/2023; Lot #: GS036194, exp. date: 06/2023; Lot #: GS036760, GS036981,GS037526, GS038177 or GS038728, exp. date: 08/2023; Lot #: GS038729 or GS041108, exp. date: 09/2023; Lot #: GS039412, GS039840 or GS041109, exp. date: 12/2023; Lot #: GS041655, exp. date: 01/2024; Lot #: GS041656, exp. date: 05/2024; Lot #: GS035031 or GS035199, exp. date: 03/2022; Lot #: GS036495 or GS036904, exp. date: 05/2022; Lot #: GS037401, exp. date: 09/2022; Lot #: GS037986, GS038359 or GS039560, exp. date: 11/2022; Lot #: GS041110, exp. date: 12/2022.
Eszopiclone tablets, 1 mg, 30-count bottles. Manufactured for: Macleods Pharma USA, Inc. Manufactured by: Macleods Pharmaceuticals Ltd. Lot #: BEK2009A, exp. date: 11/2023.
Losartan potassium tablets; 25, 50 or 100 mg; 90-tablet bottles. Marketed and packaged by: PD-Rx Pharmaceuticals, Inc. Manufactured by: Vivimed Life Sciences Private Limited. Lot #: D21C18, exp. date: 09/30/22; Lot #: E21A28, exp. date: 09/30/22; Lot #: E21C04, exp. date: 09/30/22; Lot #: E21D59, exp. date: 09/30/22; Lot #: G21B65, exp. date: 09/30/22; Lot #: H21A12, exp. date: 09/30/22; Lot #: H21D42, exp. date: 09/30/22; Lot #: K21D19, exp. date: 10/31/22; Lot #: A22A73, exp. date: 10/31/22; Lot #: D21D63, exp. date: 11/30/22; Lot #: E21A73, exp. date: 11/30/22; Lot #: E21D35, exp. date: 11/30/22; Lot #: F21A28, exp. date: 11/30/22; Lot #: F21D04, exp. date: 09/30/22; Lot #: G21B03, exp. date: 11/30/22; Lot #: G21E23, exp. date: 11/30/22; Lot #: H21B46, exp. date: 11/30/22; Lot #: H21D46, exp. date: 08/31/23; Lot #: H21D46, exp. date: 08/31/23; Lot #: I21B67, exp. date: 01/31/23; Lot #: J21A26, exp. date: 01/31/23; Lot #: J21C44, exp. date: 01/31/23; Lot #: G21C26, exp. date: 07/31/22; Lot #: H21B96, exp. date: 07/31/22; Lot #: I21B39, exp. date: 07/31/22; Lot #: I21C44, exp. date: 07/31/22; Lot #: D21F35, exp. date: 10/31/22; Lot #: E21A66, exp. date: 10/31/22; Lot #: E21C72, exp. date: 10/31/22; Lot #: E21F01, exp. date: 10/31/22; Lot #: F21C15, exp. date: 10/31/22; Lot #: F21E19, exp. date: 10/31/22; Lot #: G21B14, exp. date: 10/31/22; Lot #: K21A61, exp. date: 11/30/22; Lot #: L21A45, exp. date: 11/30/22.
Losartan potassium & hydrochlorothiazide tablets; 100 mg/25 mg; 30, 90 or 1,000 tablets. Manufactured by: Macleods Pharma USA, Inc. Lot #: BLM2114A, exp. date: 07/2023.
Morphine sulfate extended-release tablets, 30 or 60 mg, 100-count bottles. Manufactured by: Ohm Laboratories Inc. Lot #: 179642, exp. date: 11/30/2023; Lot #: 179643, exp. date: 08/31/2023.
Tretinoin capsules, 10 mg, 100 capsules per bottle. Teva Pharmaceuticals USA Inc. Lot #: 100022971, exp. date: 08/2022; Lot #: 100022972, exp. date: 05/2023; Lot #: 100028920, exp. date: 09/2023.
Zileuton extended-release tablets, 600 mg, 120-count bottle. Manufactured for: Lupin Pharmaceuticals, Inc. Lot #: M100070 or M100239, exp. date: 06/22; Lot #: M100312, exp. date: 09/22; Lot #: M100366, exp. date: 10/22.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.